A phase 3 study (PATHWAY) of palbociclib plus tamoxifen in patients with HR-positive/HER2-negative a...
A phase 3 study (PATHWAY) of palbociclib plus tamoxifen in patients with HR-positive/HER2-negative advanced breast cancer
About this item
Full title
Author / Creator
Noguchi, Emi , Yamanaka, Takashi , Mukai, Hirofumi , Yamamoto, Naohito , Chung, Chi-Feng , Lu, Yen-Shen , Chang, Dwan-Ying , Sohn, Joohyuk , Kim, Gun Min , Lee, Kyung-Hun , Lee, Soo-Chin , Iwasa, Tsutomu , Iwata, Hiroji , Watanabe, Kenichi , Jung, Kyung Hae , Tanabe, Yuko , Kang, Seok Yun , Yasojima, Hiroyuki , Aogi, Kenjiro , Tokunaga, Eriko , Sim, Sung Hoon , Yap, Yoon Sim , Matsumoto, Koji , Tseng, Ling-Ming , Umeyama, Yoshiko , Sudo, Kazuki , Kojima, Yuki , Hata, Tomomi , Kuchiba, Aya , Shibata, Taro , Nakamura, Kenichi , Fujiwara, Yasuhiro , Tamura, Kenji and Yonemori, Kan
Publisher
London: Nature Publishing Group UK
Journal title
Language
English
Formats
Publication information
Publisher
London: Nature Publishing Group UK
Subjects
More information
Scope and Contents
Contents
Palbociclib combined with endocrine therapy is approved for treating patients with hormone-receptor-positive/human epidermal growth factor receptor 2-negative (HR+/HER2−) advanced breast cancer; however, data on palbociclib combined with tamoxifen are limited. We investigated the efficacy and safety of palbociclib–tamoxifen in patients with HR+/HER...
Alternative Titles
Full title
A phase 3 study (PATHWAY) of palbociclib plus tamoxifen in patients with HR-positive/HER2-negative advanced breast cancer
Authors, Artists and Contributors
Author / Creator
Yamanaka, Takashi
Mukai, Hirofumi
Yamamoto, Naohito
Chung, Chi-Feng
Lu, Yen-Shen
Chang, Dwan-Ying
Sohn, Joohyuk
Kim, Gun Min
Lee, Kyung-Hun
Lee, Soo-Chin
Iwasa, Tsutomu
Iwata, Hiroji
Watanabe, Kenichi
Jung, Kyung Hae
Tanabe, Yuko
Kang, Seok Yun
Yasojima, Hiroyuki
Aogi, Kenjiro
Tokunaga, Eriko
Sim, Sung Hoon
Yap, Yoon Sim
Matsumoto, Koji
Tseng, Ling-Ming
Umeyama, Yoshiko
Sudo, Kazuki
Kojima, Yuki
Hata, Tomomi
Kuchiba, Aya
Shibata, Taro
Nakamura, Kenichi
Fujiwara, Yasuhiro
Tamura, Kenji
Yonemori, Kan
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_3cba658e7441401e9b9e50ad16a29171
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_3cba658e7441401e9b9e50ad16a29171
Other Identifiers
ISSN
2374-4677
E-ISSN
2374-4677
DOI
10.1038/s41523-024-00684-w
